Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer

BACKGROUND: Pre-clinical studies have demonstrated that natural and synthetic histone deacetylase (HDAC) inhibitors can impede the in vitro and in vivo growth of cell lines from a variety of gynecologic and other malignancies. We investigated the anti-tumor activity of panobinostat (LBH589) both in...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, Leslie A., Growdon, Whitfield B., Rueda, Bo R., Foster, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025559/
https://www.ncbi.nlm.nih.gov/pubmed/27633667
http://dx.doi.org/10.1186/s13048-016-0267-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025559/
https://www.ncbi.nlm.nih.gov/pubmed/27633667
http://dx.doi.org/10.1186/s13048-016-0267-2

Ejemplares similares